0 Ratings
ID

41189

Description

BELIEF (Bevacizumab and ErLotinib In EGFR Mut+ NSCLC); ODM derived from: https://clinicaltrials.gov/show/NCT01562028

Link

https://clinicaltrials.gov/show/NCT01562028

Keywords

Versions (1)
  1. 7/8/20 7/8/20 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

July 8, 2020

DOI

To request one please log in.

License

Creative Commons BY-NC 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

  • Newest
  • Oldest
  • Popular
  • Newest
    • Newest
    • Oldest
    • Popular

    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Eligibility Lung Cancer NCT01562028

    English

    Eligibility Lung Cancer NCT01562028

    1 forms  
    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    age ≥ 18 years
    Description

    Age

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0001779
    ecog performance status 0-2
    Description

    ECOG performance status

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C1520224
    adequate haematological function, coagulation, liver function and renal function
    Description

    Hematologic function | Coagulation function analysis | Liver function | Renal function

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0221130
    UMLS CUI [2]
    C3516400
    UMLS CUI [3]
    C0232741
    UMLS CUI [4]
    C0232804
    pathological diagnosis of predominantly non-squamous, non-small-cell lung cancer (nsclc)
    Description

    Non-squamous non-small cell lung cancer

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C4324656
    tnm version 7 stage iv disease including m1a (malignant effusion) or m1b (distant metastasis), or locally advanced disease not amenable to curative treatment (including patients progressing after radiochemotherapy for stage iii disease)
    Description

    Disease TNM clinical staging | Advanced disease Locally | Disease Inappropriate Curative treatment | Disease Progression | Status post Chemoradiotherapy Disease TNM clinical staging

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0012634
    UMLS CUI [1,2]
    C3258246
    UMLS CUI [2,1]
    C0679246
    UMLS CUI [2,2]
    C1517927
    UMLS CUI [3,1]
    C0012634
    UMLS CUI [3,2]
    C1548788
    UMLS CUI [3,3]
    C1273390
    UMLS CUI [4]
    C0242656
    UMLS CUI [5,1]
    C0231290
    UMLS CUI [5,2]
    C0436307
    UMLS CUI [5,3]
    C0012634
    UMLS CUI [5,4]
    C3258246
    measurable or evaluable disease (according to recist 1.1 criteria).
    Description

    Measurable Disease | Evaluable Disease

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C1513041
    UMLS CUI [2]
    C1516986
    centrally confirmed egfr exon 19 deletion (del19) or exon 21 mutation (l858r)
    Description

    EGFR exon 19 deletion | EGFR Exon 21 Mutation

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C3889117
    UMLS CUI [2]
    C4289654
    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    patients with increased risk of bleeding
    Description

    High risk of bleeding

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C4039184
    patients with clinically significant cardiovascular diseases
    Description

    Cardiovascular Disease

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0007222
    patients with a history of thrombosis or thromboembolism in the 6 months prior to treatment
    Description

    Thrombosis | Thromboembolism

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0040053
    UMLS CUI [2]
    C0040038
    patients with gastrointestinal problems
    Description

    Gastrointestinal problem

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0017187
    patients with neurologic problems
    Description

    Nervous system problem

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0221571
    C0154091 patients who have had in the past 5 years any previous or concomitant malignancy except adequately treated basal or squamous cell carcinoma of the skin, in situ carcinoma of the cervix or bladder, in situ breast carcinoma.
    Description

    Malignant Neoplasm | Exception Basal cell carcinoma Treated | Exception Squamous cell carcinoma of skin Treated | Exception Carcinoma in situ of uterine cervix Treated | Exception Carcinoma in situ of bladder Treated | Exception Carcinoma in situ of female breast Treated

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0006826
    UMLS CUI [2,1]
    C1705847
    UMLS CUI [2,2]
    C0007117
    UMLS CUI [2,3]
    C1522326
    UMLS CUI [3,1]
    C1705847
    UMLS CUI [3,2]
    C0553723
    UMLS CUI [3,3]
    C1522326
    UMLS CUI [4,1]
    C1705847
    UMLS CUI [4,2]
    C0851140
    UMLS CUI [4,3]
    C1522326
    UMLS CUI [5,1]
    C1705847
    UMLS CUI [5,2]
    C0154091
    UMLS CUI [5,3]
    C1522326
    UMLS CUI [6,1]
    C1705847
    UMLS CUI [6,2]
    C0686288
    UMLS CUI [6,3]
    C1522326
    patients with any known significant ophthalmologic anomaly of the ocular surface
    Description

    Anomaly of eye Surface of eye

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C4076038
    UMLS CUI [1,2]
    C4321570
    patients who received prior chemotherapy for metastatic disease
    Description

    Prior Chemotherapy Neoplasm Metastasis

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C1514457
    UMLS CUI [1,2]
    C0027627
    patients who received previous treatment for lung cancer with drugs targeting egfr or vegf
    Description

    Prior Therapy Malignant neoplasm of lung | EGFR targeted therapy | VEGF targeted therapy

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C1514463
    UMLS CUI [1,2]
    C0242379
    UMLS CUI [2]
    C4733187
    UMLS CUI [3]
    C4733192
    pregnancy
    Description

    Pregnancy

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0032961
    Back to the top of the page

    Similar models

    Eligibility Lung Cancer NCT01562028

    1 forms
    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    C1512693 (UMLS CUI)
    Age
    Item
    age ≥ 18 years
    boolean
    C0001779 (UMLS CUI [1])
    ECOG performance status
    Item
    ecog performance status 0-2
    boolean
    C1520224 (UMLS CUI [1])
    Hematologic function | Coagulation function analysis | Liver function | Renal function
    Item
    adequate haematological function, coagulation, liver function and renal function
    boolean
    C0221130 (UMLS CUI [1])
    C3516400 (UMLS CUI [2])
    C0232741 (UMLS CUI [3])
    C0232804 (UMLS CUI [4])
    Non-squamous non-small cell lung cancer
    Item
    pathological diagnosis of predominantly non-squamous, non-small-cell lung cancer (nsclc)
    boolean
    C4324656 (UMLS CUI [1])
    Disease TNM clinical staging | Advanced disease Locally | Disease Inappropriate Curative treatment | Disease Progression | Status post Chemoradiotherapy Disease TNM clinical staging
    Item
    tnm version 7 stage iv disease including m1a (malignant effusion) or m1b (distant metastasis), or locally advanced disease not amenable to curative treatment (including patients progressing after radiochemotherapy for stage iii disease)
    boolean
    C0012634 (UMLS CUI [1,1])
    C3258246 (UMLS CUI [1,2])
    C0679246 (UMLS CUI [2,1])
    C1517927 (UMLS CUI [2,2])
    C0012634 (UMLS CUI [3,1])
    C1548788 (UMLS CUI [3,2])
    C1273390 (UMLS CUI [3,3])
    C0242656 (UMLS CUI [4])
    C0231290 (UMLS CUI [5,1])
    C0436307 (UMLS CUI [5,2])
    C0012634 (UMLS CUI [5,3])
    C3258246 (UMLS CUI [5,4])
    Measurable Disease | Evaluable Disease
    Item
    measurable or evaluable disease (according to recist 1.1 criteria).
    boolean
    C1513041 (UMLS CUI [1])
    C1516986 (UMLS CUI [2])
    EGFR exon 19 deletion | EGFR Exon 21 Mutation
    Item
    centrally confirmed egfr exon 19 deletion (del19) or exon 21 mutation (l858r)
    boolean
    C3889117 (UMLS CUI [1])
    C4289654 (UMLS CUI [2])
    Item Group
    C0680251 (UMLS CUI)
    High risk of bleeding
    Item
    patients with increased risk of bleeding
    boolean
    C4039184 (UMLS CUI [1])
    Cardiovascular Disease
    Item
    patients with clinically significant cardiovascular diseases
    boolean
    C0007222 (UMLS CUI [1])
    Thrombosis | Thromboembolism
    Item
    patients with a history of thrombosis or thromboembolism in the 6 months prior to treatment
    boolean
    C0040053 (UMLS CUI [1])
    C0040038 (UMLS CUI [2])
    Gastrointestinal problem
    Item
    patients with gastrointestinal problems
    boolean
    C0017187 (UMLS CUI [1])
    Nervous system problem
    Item
    patients with neurologic problems
    boolean
    C0221571 (UMLS CUI [1])
    Malignant Neoplasm | Exception Basal cell carcinoma Treated | Exception Squamous cell carcinoma of skin Treated | Exception Carcinoma in situ of uterine cervix Treated | Exception Carcinoma in situ of bladder Treated | Exception Carcinoma in situ of female breast Treated
    Item
    C0154091 patients who have had in the past 5 years any previous or concomitant malignancy except adequately treated basal or squamous cell carcinoma of the skin, in situ carcinoma of the cervix or bladder, in situ breast carcinoma.
    boolean
    C0006826 (UMLS CUI [1])
    C1705847 (UMLS CUI [2,1])
    C0007117 (UMLS CUI [2,2])
    C1522326 (UMLS CUI [2,3])
    C1705847 (UMLS CUI [3,1])
    C0553723 (UMLS CUI [3,2])
    C1522326 (UMLS CUI [3,3])
    C1705847 (UMLS CUI [4,1])
    C0851140 (UMLS CUI [4,2])
    C1522326 (UMLS CUI [4,3])
    C1705847 (UMLS CUI [5,1])
    C0154091 (UMLS CUI [5,2])
    C1522326 (UMLS CUI [5,3])
    C1705847 (UMLS CUI [6,1])
    C0686288 (UMLS CUI [6,2])
    C1522326 (UMLS CUI [6,3])
    Anomaly of eye Surface of eye
    Item
    patients with any known significant ophthalmologic anomaly of the ocular surface
    boolean
    C4076038 (UMLS CUI [1,1])
    C4321570 (UMLS CUI [1,2])
    Prior Chemotherapy Neoplasm Metastasis
    Item
    patients who received prior chemotherapy for metastatic disease
    boolean
    C1514457 (UMLS CUI [1,1])
    C0027627 (UMLS CUI [1,2])
    Prior Therapy Malignant neoplasm of lung | EGFR targeted therapy | VEGF targeted therapy
    Item
    patients who received previous treatment for lung cancer with drugs targeting egfr or vegf
    boolean
    C1514463 (UMLS CUI [1,1])
    C0242379 (UMLS CUI [1,2])
    C4733187 (UMLS CUI [2])
    C4733192 (UMLS CUI [3])
    Pregnancy
    Item
    pregnancy
    boolean
    C0032961 (UMLS CUI [1])
    Back to the top of the page 

    Help

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial